Alignment Healthcare Inc
ALHC16.770USD
-0.949-5.36%
Handelsschluss 05/01, 16:00（ET）Kurse um 15 Minuten verzögert
3.22BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Alignment Healthcare Inc Unternehmen
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
Unternehmensinformationen
Unternehmens-codeALHC
Name des UnternehmensAlignment Healthcare Inc
IPO-datumMar 26, 2021
Gegründet am2014
CEOMr. John E. Kao
Anzahl der mitarbeiter1679
WertpapierartOrdinary Share
GeschäftsjahresendeMar 26
Addresse1100 W. Town And Country Road
StadtORANGE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl92868
Telefon18443102247
Websitehttps://www.alignmenthealth.com/
Unternehmens-codeALHC
IPO-datumMar 26, 2021
Gegründet am2014
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
Mr. Sebastian Burzacchi
Mr. Sebastian Burzacchi
Chief Operating Officer - Management Services Organization
Chief Operating Officer - Management Services Organization
250.38K
+15.17%
Ms. Margaret M. (Meg) Mccarthy
Ms. Margaret M. (Meg) Mccarthy
Lead Independent Director
Lead Independent Director
95.38K
+14.75%
Ms. Jody L. Bilney
Ms. Jody L. Bilney
Independent Director
Independent Director
63.77K
+32.07%
Dr. Hyong (Ken) Kim, M.D.
Dr. Hyong (Ken) Kim, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Kao
Mr. John E. Kao
Chief Executive Officer, Director
Chief Executive Officer, Director
5.35M
+68.63%
Mr. Joseph S. Konowiecki
Mr. Joseph S. Konowiecki
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
862.50K
+1.44%
Mr. Robert L. Scavo
Mr. Robert L. Scavo
Chief Information Officer
Chief Information Officer
702.95K
+60.92%
Mr. Christopher J. Joyce, J.D.
Mr. Christopher J. Joyce, J.D.
Chief Legal and Administrative Officer
Chief Legal and Administrative Officer
415.02K
-5.68%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
327.44K
+3.89%
Dr. Jacqueline B. Kosecoff
Dr. Jacqueline B. Kosecoff
Independent Director
Independent Director
250.87K
+5.14%
Umsatzaufteilung
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
2.70B
0.00%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Sun, Feb 23
Update-Zeit: Sun, Feb 23
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
Aktionärsstatistik
Aktionäre
Anteil
General Atlantic LLC
30.87%
Fidelity Management & Research Company LLC
8.28%
The Vanguard Group, Inc.
4.96%
T. Rowe Price Investment Management, Inc.
4.38%
BlackRock Institutional Trust Company, N.A.
3.91%
Other
47.61%
Art
Aktionäre
Anteil
Private Equity
30.87%
Investment Advisor
24.88%
Investment Advisor/Hedge Fund
18.98%
Hedge Fund
13.57%
Individual Investor
6.17%
Research Firm
1.17%
Pension Fund
0.18%
Bank and Trust
0.15%
Sovereign Wealth Fund
0.15%
Other
3.88%
Institutionelle Beteiligung
Update-Zeit: Sat, Feb 22
Update-Zeit: Sat, Feb 22
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
354
190.62M
96.46%
+2.56M
2024Q4
366
185.10M
96.49%
-4.29M
2024Q3
361
175.79M
91.75%
-18.07M
2024Q2
350
177.50M
92.81%
-16.13M
2024Q1
345
173.65M
90.84%
-16.06M
2023Q4
340
174.44M
92.27%
-18.71M
2023Q3
340
173.65M
91.94%
-19.56M
2023Q2
331
172.91M
91.73%
-9.35M
2023Q1
320
174.26M
93.05%
-8.71M
2022Q4
312
177.19M
94.61%
+2.71M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
General Atlantic LLC
61.03M
31.81%
+37.42K
+0.06%
Mar 13, 2025
Fidelity Management & Research Company LLC
16.37M
8.53%
-535.68K
-3.17%
Dec 31, 2024
The Vanguard Group, Inc.
9.80M
5.11%
+166.84K
+1.73%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
8.65M
4.51%
+3.06M
+54.74%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
7.72M
4.03%
+600.44K
+8.43%
Dec 31, 2024
Wellington Management Company, LLP
7.44M
3.88%
+3.26M
+77.92%
Dec 31, 2024
Deerfield Management Company, L.P.
7.30M
3.81%
-3.55M
-32.71%
Dec 31, 2024
Kao (John E)
5.35M
2.79%
+2.18M
+68.63%
Mar 27, 2025
Hood River Capital Management LLC
4.95M
2.58%
+1.41M
+39.61%
Dec 31, 2024
Durable Capital Partners LP
4.59M
2.39%
-890.72K
-16.26%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: 3 hours ago
Update-Zeit: 3 hours ago
Name
Anteil
Innovator IBD 50 Fund ETF
3.35%
SPDR S&P Health Care Services ETF
2.36%
Counterpoint Quantitative Equity ETF
2.21%
Simplify Health Care ETF
1.73%
First Trust Small Cap Growth AlphaDEX Fund
0.86%
Federated Hermes MDT Small Cap Core ETF
0.56%
First Trust Small Cap Core Alphadex Fund
0.55%
Even Herd Long Short ETF
0.55%
Langar Global HealthTech ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.3%
Mehr Anzeigen
Innovator IBD 50 Fund ETF
Anteil3.35%
SPDR S&P Health Care Services ETF
Anteil2.36%
Counterpoint Quantitative Equity ETF
Anteil2.21%
Simplify Health Care ETF
Anteil1.73%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.86%
Federated Hermes MDT Small Cap Core ETF
Anteil0.56%
First Trust Small Cap Core Alphadex Fund
Anteil0.55%
Even Herd Long Short ETF
Anteil0.55%
Langar Global HealthTech ETF
Anteil0.32%
iShares U.S. Healthcare Providers ETF
Anteil0.3%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten